Zoledronic Acid based drugs: price, availability and description

Zoledronic Acid is a potent bisphosphonate that inhibits osteoclastic bone resorption. It is widely used in oncology to prevent skeletal related events (pathological fractures, spinal cord compression) in patients with bone metastases and multiple myeloma. It is also indicated for the treatment of hypercalcemia of malignancy (HCM) and for the treatment of osteoporosis (marketed as Aclasta/Reclast).